Intermittent power supply could hamper Malawi's preparedness for the COVID-19 vaccine which is expected in the country sometime around June.
This is despite the fact that the country has not yet decide on which vaccine to go with; Astrazeneca, Mordena or Pfizer.
Principal Secretary in the Ministry of Health Charles Mwansambo said the vaccine requires ultra-cold storage and they are assessing the chain facilities.
Mwansambo feared the vaccine could be imported into the country but it is the preparedness that will be crucial in the immunization exercise.
The PS hinted Astrazeneca could be the choice of vaccine because of the two to eight degrees conditions of storage.
Pfizer requires to be stored at about minus 80 degrees centigrade while Mordena at minus 20 degrees which Mwansambo said is not possible for Malawi situation.
Mac Mallewa, Chairperson on the Committee of vaccines dispelled rumours the indemnity signing with the COVAX facility, manufacturers of the vaccines, meant the vaccine is not safe.
“We as a committee looked at the vaccine and said it was safe. Then if manufactures demanded an indemnity agreement, then we had no choice as a country,” he said.